The GUSTO Investigators.An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.N Eng J Med1993; 329: 673–82.
2.
BrophyJ.M., JosephL.Placing trials in context using Bayesian analysis. GUSTO revisited by the Reverend Bayes.JAMA1995; 273: 871–5.
3.
ChestertonG.K.The Middleman in Poetry. Essays and Poems.London: Penguin,1958.
4.
MedawarP. Is the scientific paper a fraud? The Strange Case of the Spotted Mice and Other Classic Essays on Science.Oxford: Oxford University Press,1996.
5.
IFNB Multiple Sclerosis Study Group.Interferon beta-1b is effective in relapsing—remitting multiple sclerosis.Neurology1993; 43: 655–61.
JacobsL.D., MunschauerF.E.Treatment of multiple sclerosis with interferons. In: RudickR.A., GoodkinD.E., eds. Treatment of Multiple Sclerosis: Trial Design, Results and Future Perspectives.London: Springer,1992: 223–50.
8.
HackeW., KasteM., FieschiC.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS).JAMA1995; 274: 1017–25.
9.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke.N Engl J Med1995; 333: 1581–7.
10.
HackeW., KasteM., FieschiC.Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASSII).Lancet1998; 352: 1245–51.
11.
BathP.Commentary: Alteplase not yet proven for acute ischaemic stroke.Lancet1998; 352: 1238–9.
12.
European Study Group on Interferon beta-1b in Secondary Progressive MS.Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis.Lancet1998; 352: 1491–7.
